what are the Recommendations for Patients at Risk for HF (Stage A: Primary
Prevention)
Referenced studies that support the recommendations are
summarized in the Online Data Supplements.?
In patients with type 2 diabetes and either established CVD or at high cardiovascular risk, SGLT2i should be used to prevent hospitaliza- tions for HF.